These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 9121817)
41. Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats. Otto KJ; Wyse BD; Cabot PJ; Smith MT Pain Med; 2011 May; 12(5):782-93. PubMed ID: 21481170 [TBL] [Abstract][Full Text] [Related]
43. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270 [TBL] [Abstract][Full Text] [Related]
44. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions. Araujo MC; Sinnott CJ; Strichartz GR Pain; 2003 May; 103(1-2):21-9. PubMed ID: 12749955 [TBL] [Abstract][Full Text] [Related]
45. Perfusion of the mechanically compressed lumbar ganglion with lidocaine reduces mechanical hyperalgesia and allodynia in the rat. Zhang JM; Li H; Brull SJ J Neurophysiol; 2000 Aug; 84(2):798-805. PubMed ID: 10938306 [TBL] [Abstract][Full Text] [Related]
46. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043 [TBL] [Abstract][Full Text] [Related]
47. The effects of zenarestat, an aldose reductase inhibitor, on minimal F-wave latency and nerve blood flow in streptozotocin-induced diabetic rats. Yamamoto T; Takakura S; Kawamura I; Seki J; Goto T Life Sci; 2001 Feb; 68(12):1439-48. PubMed ID: 11388695 [TBL] [Abstract][Full Text] [Related]
48. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535 [TBL] [Abstract][Full Text] [Related]
49. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174 [TBL] [Abstract][Full Text] [Related]
50. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Price SA; Agthong S; Middlemas AB; Tomlinson DR Diabetes; 2004 Jul; 53(7):1851-6. PubMed ID: 15220210 [TBL] [Abstract][Full Text] [Related]
51. Pathogenesis of spinally mediated hyperalgesia in diabetes. Ramos KM; Jiang Y; Svensson CI; Calcutt NA Diabetes; 2007 Jun; 56(6):1569-76. PubMed ID: 17287466 [TBL] [Abstract][Full Text] [Related]
52. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499 [TBL] [Abstract][Full Text] [Related]
53. Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy. Naruse K; Sato J; Funakubo M; Hata M; Nakamura N; Kobayashi Y; Kamiya H; Shibata T; Kondo M; Himeno T; Matsubara T; Oiso Y; Nakamura J PLoS One; 2011; 6(11):e27458. PubMed ID: 22125614 [TBL] [Abstract][Full Text] [Related]
54. Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model. Bujalska M; Makulska-Nowak H Neuro Endocrinol Lett; 2009 Mar; 30(1):144-52. PubMed ID: 19300402 [TBL] [Abstract][Full Text] [Related]
55. Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. Turan Yücel N; Can ÖD; Demir Özkay Ü Psychopharmacology (Berl); 2020 Apr; 237(4):1131-1145. PubMed ID: 31912189 [TBL] [Abstract][Full Text] [Related]
56. Effects of intrathecal lidocaine on hyperalgesia and allodynia following chronic constriction injury in rats. Tian J; Gu Y; Su D; Wu Y; Wang X Eur J Pain; 2009 Feb; 13(2):130-7. PubMed ID: 18486505 [TBL] [Abstract][Full Text] [Related]
57. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]
59. Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy. El-Lithy GM; El-Bakly WM; Matboli M; Abd-Alkhalek HA; Masoud SI; Hamza M Transl Res; 2016 Nov; 177():85-97.e1. PubMed ID: 27392937 [TBL] [Abstract][Full Text] [Related]
60. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Ulugol A; Karadag HC; Tamer M; Firat Z; Aslantas A; Dokmeci I Neurosci Lett; 2002 Aug; 328(2):129-32. PubMed ID: 12133572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]